Agri, Sugar & Edible Oils · Agricultural Commodities/Milling · NSE: INDOUS · data 2026-10-30

Indo US Bio-Tech Ltd.

₹73.54-6.15% on 30 OctHealth: Average 5.6/10

Feb 2026Low ₹60.31 · High ₹150.72-41.6%

In plain words

Price: 53.7% below its 52-week high of ₹159.

Delivery: 57.7% of traded shares were kept for delivery over the last 10 sessions, against 64.8% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹73.54

Market cap

₹156 cr

P/E

12.9

P/B

—

ROE

15.3%

ROCE

18.8%

Debt / equity

0.4

Dividend yield

0.00%

1-year return

-48.0%

52-week high

₹159

52-week low

₹57.5

Operating margin

12.9%

Growth

Revenue (last 12 months)	₹113 cr
Net profit (last 12 months)	₹11 cr
Sales growth, 3 years (yearly)	21.4%
Profit growth, 3 years (yearly)	21.9%

Smart-money activity

19/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 14/30: Delivery 40.6% over the last 20 sessions vs 67.8% in the 40 before (0.6x); shares delivered per day 1.45x usual; 3 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Dividend

3 Dec 24Dividend Dividend ₹0.25 (ex-date) -4.3% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is Indo US Bio-Tech Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.4.

What is Indo US Bio-Tech Ltd.'s P/E ratio?

About 12.9, based on the last 12 months' earnings and a price of ₹73.54 (data 2026-10-30).

What is the 52-week high and low of Indo US Bio-Tech Ltd.?

The 52-week high is ₹159 and the 52-week low is ₹57.5.

Similar companies

Ramdevbaba Solvent Limited (RBS) · Waterbase Limited (WATERBASE) · Dhunseri Tea & Industries Ltd (DTIL) · Mangalam Seeds Ltd (MSL) · Dollex Agrotech Limited (DOLLEX)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open INDOUS in NSE Scanner →